|
Active Research Studies for PRIMARY LUNG CANCER

ECOG E5597 Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non-Small Cell Lung Cancer
CINJOG 030801 – (Phase I & II – advanced, Stage IIIB, IV or recurrent NSCLC)
Modulation of autophagy with Hydroxychloroquine in combination with Carboplatin, paclitaxel & Avastin.
Dose of Hydroxycholoruine TBD during Phase I. After dose is determined, we can start accuring.
ECOG E1505 A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for patients with Completely Resected Stage IB (>4cm) – IIIA Non-Small Cell Lung Cancer (NSCLC)
|